Oliver Micke

Intravenous amifostine during chemoradiotherapy for head-and-neck cancer: A randomized placebo-controlled phase III study

Jens Buentzel, Oliver Micke, Irenäus A. Adamietz et al. · International Journal of Radiation Oncology*Biology*Physics · 2005 · 148 citations

Medicine, Oncology, Radiation Oncology +10

User rate of complementary and alternative medicine (CAM) of patients visiting a counseling facility for CAM of a German comprehensive cancer center.

Jutta Huebner, Oliver Micke, Ralph Muecke et al. · PubMed · 2014 · 123 citations

Medicine, Oncology, Clinical Medicine +6

Radiation therapy for aggressive fibromatosis (desmoid tumors): Results of a national Patterns of Care Study

Oliver Micke, M. Heinrich Seegenschmiedt · International Journal of Radiation Oncology*Biology*Physics · 2005 · 118 citations

Medicine, Oncology, Radiation Oncology +12

Multicenter, Phase 3 Trial Comparing Selenium Supplementation With Observation in Gynecologic Radiation Oncology

Ralph Muecke, Lutz Schomburg, Michael Glatzel et al. · International Journal of Radiation Oncology*Biology*Physics · 2010 · 115 citations

Medicine, Oncology, Radiation Oncology +11

Predictive factors for the use of complementary and alternative medicine (CAM) in radiation oncology

Oliver Micke, Frank Bruns, Michael Glatzel et al. · European Journal of Integrative Medicine · 2009 · 114 citations

Medicine, Oncology, Radiation Oncology +16